Pure Global AI
ANVISA registration 80254180476Active

BETA GONADOTROFINA CORIÔNICA HUMANA (BHCG) - RASTREAMENTO, DIAGNÓSTICO OU ESTADIAMENTO DE CÂNCER/DESORDENS CONGÊNITAS

ANVISA Registration Number: 80254180476PHADIA DIAGNOSTICOS LTDAB·R·A·H·M·S GMBHRisk Class III
Verified
Device names
Technical name
BETA GONADOTROFINA CORIÔNICA HUMANA (BHCG) - RASTREAMENTO, DIAGNÓSTICO OU ESTADIAMENTO DE CÂNCER/DESORDENS CONGÊNITAS
View exact technical-name matches →
Commercial name
Família BRAHMS Free ßhCG KRYPTOR
View exact commercial-name matches →
Risk class
Class III
Registration details
Registration Number
80254180476
Process Number
25351434056202491
CNPJ
04930429000139
Company information
Registration Holder
PHADIA DIAGNOSTICOS LTDA
Manufacturer
B·R·A·H·M·S GMBH
Manufacturing Country
Germany
PT: ALEMANHA
Dates and status
Publication Date
Mar 05, 2025
Status
Active
About this record

Access comprehensive regulatory information for BETA GONADOTROFINA CORIÔNICA HUMANA (BHCG) - RASTREAMENTO, DIAGNÓSTICO OU ESTADIAMENTO DE CÂNCER/DESORDENS CONGÊNITAS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80254180476 and manufactured by B·R·A·H·M·S GMBH. The registration is held by PHADIA DIAGNOSTICOS LTDA with validity until Mar 05, 2035.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.